Stay updated on NICHE: Clinical Trial on IO in Early Colon Cancer
Sign up to get notified when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.

Latest updates to the NICHE: Clinical Trial on IO in Early Colon Cancer page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study protocols and patient criteria for a clinical trial on neoadjuvant immune checkpoint inhibition in early-stage colon cancer, while adding new drug names and collaborators.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to NICHE: Clinical Trial on IO in Early Colon Cancer
Enter your email address, and we'll notify you when there's something new on the NICHE: Clinical Trial on IO in Early Colon Cancer page.